[Basel, Switzerland, April 23rd, 2025] – The global beta-blocker market, valued at 4.8 billion in 2023, is projected to grow at 5.2% to 7.2 billion by 2031, according to ClearView Market Insights. Innovations in extended-release formulations and transdermal delivery systems are transforming this essential drug class.
Request Sample @...
